**Author details**

Miltiadis K. Tsilimbaris\* , Chrysanthi Tsika, George Kontadakis and Athanassios Giarmoukakis

\*Address all correspondence to: tsilimb@med.uoc.gr

University of Crete, Medical School, Department of Ophthalmology, Crete, Greece

#### **References**


[12] Roth AM, Foos RY. Surface wrinkling retinopathy in eyes enucleated at autopsy. Trans Am Acad Ophthalmol Otolaryngol. 1971;75(5):1047-58.

**Author details**

130 Advances in Eye Surgery

**References**

Miltiadis K. Tsilimbaris\*

Athanassios Giarmoukakis

1982;94:44-8.

1178-1184.

1989;96:389-92.

104: 1033-40.

mol. 1985;17:378-80.

Mo: Mosby; 1997:938-50.

\*Address all correspondence to: tsilimb@med.uoc.gr

Arch Clin Exp Ophthalmol. 1865; 11: 135-70.

mic Surg Lasers. 2000; 31: 192-197.

patients. Am J Ophthalmol. 2000; 130: 669-670

tachment surgery. Ophthalmic Surg. 1992;23:116-9.

, Chrysanthi Tsika, George Kontadakis and

[1] Iwanoff A. Beiträge zur normalen und pathologischen Anatomie des Auges. Graefes

[2] Sidd RJ, Fine SL, Owens SL, Patz A. Idiopathic preretinal gliosis. Am J Ophthalmol.

[3] Sheard RM, Sethi C, Gregor Z. Acute macular pucker. Ophthalmology. 2003; 110:

[4] Rivellese M, George A, Sulkes D, Reichel E, Puliafito C. Optical coherence tomogra‐ phy after laser photocoagulation for clinically significant macular edema. Ophthal‐

[5] Hassenstein A, Bialasiewicz AA, Richard G. Optical coherence tomography in uveitis

[6] Uemura A, Ideta H, Nagasaki H, Morita H, Ito k. Macular pucker after retinal de‐

[7] Appiah AP, Hirose T. Secondary causes of premacular fibrosis. Ophthalmology.

[8] Meyers SM, Gutman FA, Kaye LD, Rothner AD. Retinal changes associated with

[9] Gass JDM. Macular dysfunction caused by epiretinal membrane contraction. In: Ster‐ eoscopic Atlas of Macular Diseases: Diagnosis and Treatment. Vol. 2, 4th ed. St Louis,

[10] Mitchell P, Smith W, Chey T, Wang JJ, Chang A. Prevalence and associations of epi‐ retinal membranes. The Blue Mountains Eye Study, Australia. Ophthalmology 1997;

[11] Pearlstone AD. The incidence of idiopathic preretinal macular gliosis. Ann Ophthal‐

neurofibromatosis 2.Trans Am Ophthalmol Soc 1995; 93: 245-52.

University of Crete, Medical School, Department of Ophthalmology, Crete, Greece


[40] Messner KH. Spontaneous separation of preretinal macular fibrosis. Am J Ophthal‐ mol. 1977; 83:9-11.

[27] Harada C, Mitamura Y, Harada T. The role of cytokines and trophic factors in epireti‐ nal membranes: involvement of signal transduction in glial cells. Prog Retin Eye Res.

[28] Harada T, Harada C, Mitamura Y, Akazawa C, Ohtsuka K, Ohno S, Takeuchi S, Wa‐ da K. Neurotrophic factor receptors in epiretinal membranes after human diabetic

[29] Chen YS, Hackett SF, Schoenfeld CL, Vinores MA, Vinores SA, Campochiaro PA. Lo‐ calisation of vascular endothelial growth factor and its receptors to cells of vascular

[30] Minchiotti S, Stampachiacchiere B, Micera A, Lambiase A, Ripandelli G, Billi B, Boni‐ ni S. Human idiopathic epiretinal membranes express NGF and NGF receptors. Reti‐

[31] Iannetti L, Accorinti M, Malagola R, Bozzoni-Pantaleoni F, Da Dalt S, Nicoletti F, Gradini R, Traficante A, Campanella M, Pivetti-Pezzi P. Role of the intravitreal growth factors in the pathogenesis of idiopathic epiretinal membrane. Invest Oph‐

[32] Mandelcorn E, Khan Y, Javorska L, Cohen J, Howarth D, Mandelcorn M. Idiopathic epiretinal membranes: cell type, growth factor expression, and fluorescein angio‐ graphic and retinal photographic correlations. Can J Ophthalmol. 2003 ;38(6):457-63.

[33] Joshi M, Agrawal S, Christoforidis JB. Inflammatory mechanisms of idiopathic epire‐

[34] Mandal N, Kofod M, Vorum H, Villumsen J, Eriksen J, Heegaard S, Prause JU, Ahuja S, Honoré B, la Cour M. Proteomic analysis of human vitreous associated with idio‐

[35] Fraser-Bell S, Guzowski M, Rochtchina et al. Five-Year Cumulative Incidence and Progression of Epiretinal Membranes The Blue Mountains Eye Study. Ophthalmolo‐

[36] Hayashi K, Hayashi H. Influence of phacoemulsification surgery on progression of

[37] Charlap RS, Yagoda AD, Debbi S, Bodine SR, Walsh JB, Henkind P. Idiopathic prere‐ tinal macular gliosis: a retrospective study of 200 patients. Ann Ophthalmol. 1992;

[38] Wiznia RA. Natural history of idiopathic preretinal macular fibrosis. Ann Ophthal‐

[39] Wise GN. Clinical features of idiopathic preretinal macular fibrosis. Am J Ophthal‐

tinal membrane formation. Mediators Inflamm. 2013;2013:192582.

pathic epiretinal membrane. Acta Ophthalmol. 2013; 91(4):333-4.

idiopathic epiretinal membrane. Eye. 2009; 23(4):774-9.

and avascular epiretinal membranes. Br J Ophthalmol. 1997;81(10):919-26.

retinopathy. Diabetes Care. 2002 Jun;25(6):1060-5.

2006; 25(2):149-64.

132 Advances in Eye Surgery

na. 2008; 28(4):628-37.

gy 2003;110:34-40.

24(10):381-5.

mol. 1982; 14:876-878.

mol. 1975; 79:349-357.

thalmol Vis Sci. 2011; 52(8):5786-9.


[65] Konstantinidis L, Berguiga M, Beknazar E, Wolfensberger TJ. Anatomic and func‐ tional outcome after 23-gauge vitrectomy, peeling, and intravitreal triamcinolone for idiopathic macular epiretinal membrane. Retina 2009;29:1119-1127.

[52] Galway G, Drury B, Cronin BG, Bourke RD. A comparison of induced astigmatism in

[53] Valmaggia C. Pars plana vitrectomy with 25-gauge instruments in the treatment of idiopathic epiretinal membranes. Klin Monbl Augenheilkd. 2007;224:292-296.

[54] Thompson JT. Advantages and limitations of small gauge vitrectomy. Surv Ophthal‐

[55] Spitznas M. A binocular indirect ophthalmomicroscope (BIOM) for non-contact wide-angle vitreous surgery. Graefes Arch Clin Exp Ophthalmol. 1987;225:13-15. [56] Hernandez F, Alpizar-Alvarez N, Wu L. Chromovitrectomy: an update. Journal of

[57] Kwok AK, Lai TY, Li WW, Yew DT, Wong VW. Trypan blue- and indocyanine green-assisted epiretinal membrane surgery: clinical and histopathological studies.

[58] Feron EJ, Veckeneer M, Parys-Van Ginderdeuren R, Van Lommel A, Melles GR, Stal‐ mans P. Trypan blue staining of epiretinal membranes in proliferative vitreoretinop‐

[59] Creuzot-Garcher C, Acar N, Passemard M, Bidot S, Bron A, Bretillon L. Functional and structural effect of intravitreal indocyanine green, triamcinolone acetonide, try‐

[60] Lesnik Oberstein SY, Mura M, Tan SH, de Smet MD. Heavy trypan blue staining of epiretinal membranes: an alternative to infracyanine green. Br J Ophthalmol.

[61] Totan Y, Guler E, Dervisogullari MS. Brilliant Blue G assisted epiretinal membrane

[62] Shimada H, Nakashizuka H, Hattori T, Mori R, Mizutani Y, Yuzawa M. Double staining with brilliant blue G and double peeling for epiretinal membranes. Ophthal‐

[63] Penha FM, Pons M, Costa Ede et al. Effect of vital dyes on retinal pigmented epithe‐ lial cell viability and apoptosis: implications for chromovitrectomy. Ophthalmologi‐

[64] Penha FM, Pons M, Costa EF, Barros NM, Rodrigues EB, Cardoso EB, Dib E, Maia M, Marin-Castaño ME, Farah ME. Retinal pigmented epithelial cells cytotoxicity and apoptosis through activation of the mitochondrial intrinsic pathway: role of indocya‐ nine green, brilliant blue and implications for chromovitrectomy. PloS one

pan blue, and brilliant blue g on rat retina. Retina. 2010;30:1294-1301.

20- vs 25-gauge vitrectomy procedures. Eye 2010;24:315-317.

ophthalmic & vision research 2014;9:251-259.

athy. Arch Ophthalmol. 2002;120:141-144.

mol. 2011;56:162-172.

134 Advances in Eye Surgery

Eye. 2004;18:882-888.

2007;91:955-957.

surgery. Sci Rep. 2014;4:3956.

mology 2009;116:1370-1376.

ca. 2013;230 Suppl 2:41-50.

2013;8:e64094.


[92] Dave VP, Pathengay A, Schwartz SG, Flynn HW Jr. Endophthalmitis following pars plana vitrectomy: a literature review of incidence, causative organisms, and treat‐ ment outcomes. Clin Ophthalmol. 2014;8:2183-2188.

[80] Benhamou N, Massin P, Spolaore R, Paques M, Gaudric A. Surgical management of epiretinal membrane in young patients. Am J Ophthalmol. 2002;133:358-364.

[81] Falkner-Radler CI, Glittenberg C, Hagen S, Benesch T, Binder S. Spectral-domain op‐ tical coherence tomography for monitoring epiretinal membrane surgery. Ophthal‐

[82] Kinoshita T, Imaizumi H, Okushiba U, Miyamoto H, Ogino T, Mitamura Y. Time course of changes in metamorphopsia, visual acuity, and OCT parameters after suc‐

[83] Kim J, Rhee KM, Woo SJ, Yu YS, Chung H, Park KH. Long-term temporal changes of macular thickness and visual outcome after vitrectomy for idiopathic epiretinal

[84] Hashimoto Y, Saito W, Saito M, Hirooka K, Fujiya A, Yoshizawa C, Noda K, Ishida S. Retinal outer layer thickness increases after vitrectomy for epiretinal membrane, and visual improvement positively correlates with photoreceptor outer segment length.

[85] Pichi F, Lembo A, Morara M, Veronese C, Alkabes M, Nucci P, Ciardella AP. Early and late inner retinal changes after inner limiting membrane peeling. Int Ophthal‐

[86] Kumagai K, Ogino N, Furukawa M, Hangai M, Kazama S, Nishigaki S, Larson E. Retinal thickness after vitrectomy and internal limiting membrane peeling for macu‐

[87] Hsu YR, Yang CM, Yeh PT. Clinical and histological features of epiretinal membrane after diabetic vitrectomy. Graefes Arch Clin Exp Ophthalmol. 2014;252:401-410. [88] Martinez-Castillo V, Boixadera A, Distefano L, Zapata M, Garcia-Arumi J. Epiretinal membrane after pars plana vitrectomy for primary pseudophakic or aphakic rheg‐ matogenous retinal detachment: incidence and outcomes. Retina. 2012;32:1350-1355.

[89] Tanawade RG, Tsierkezou L, Bindra MS, Patton NA, Jones NP. Visual Outcomes of Pars Plana Vitrectomy with Epiretinal Membrane Peel in Patients with Uveitis. Reti‐

[90] Yiu G, Marra KV, Wagley S, Krishnan S, Sandhu H, Kovacs K, Kuperwaser M, Ar‐ royo JG. Surgical outcomes after epiretinal membrane peeling combined with cata‐

[91] Pournaras CJ, Emarah A, Petropoulos IK. Idiopathic macular epiretinal membrane surgery and ILM peeling: anatomical and functional outcomes. Semin Ophthalmol.

lar hole and epiretinal membrane. Clin Ophthalmol. 2012;6:679-688.

cessful epiretinal membrane surgery. IOVS. 2012;53:3592-3597.

membrane. Am J Ophthalmol. 2010;150:701-709.

Graefes Arch Clin Exp Ophthalmol. 2014;252:219-226.

ract surgery. Br J Ophthalmol. 2013;97:1197-1201.

mology. 2010;117:798-805.

136 Advances in Eye Surgery

mol. 2014;34:437-446.

na. 2014 [In Press].

2011;26:42-46.

